Scintigraphy for Feline Hyperthyroidism

Harvey, A. M., A. Hibbert, et al. (2009). "Scintigraphic findings in 120 hyperthyroid cats." Journal of Feline Medicine & Surgery 11(2): 96-106.

The purpose of this study performed at the University of Bristol, United Kingdom, was to characterize the scintigraphic findings in a group of cats with hyperthyroidism to determine the location of the abnormal thyroid tissue. Thyroid scintigraphy relies on the selective uptake of a radionuclide by thyroid tissue. Hyperthyroidism is diagnosed by the increased level of uptake by the thyroid gland compared with salivary gland tissue. Thyroid scintigraphy also demonstrates the location of the abnormal thyroid tissue, which is useful when planning treatment options. The database of the Feline Centre at the University of Bristol was searched for cases of feline hyperthyroidism with good quality scintigraphic images between 1994 and 2007. Images from 120 cats were evaluated. Almost 1 in 5 hyperthyroid cats was found to have multiple areas of abnormal thyroid tissue and/or intrathoracic thyroid tissue where surgical thyroidectomy would not be curative. Another finding was that scintigraphy could not reliably differentiate between thyroid carcinoma and adenoma. The authors conclude that the possible presence of ectopic thyroid tissue should be discussed with all owners of hyperthyroid cats prior to performing surgical thyroidectomy. [SL]
>> PubMed Abstract

Related articles:
Henrikson, T. D., L. J. Armbrust, et al. (2005). "Thyroid to salivary ratios determined by technetium-99m pertechnetate imaging in thirty-two euthyroid cats." Vet Radiol Ultrasound 46(6): 521-3.
>> PubMed Abstract

Naan, E. C., J. Kirpensteijn, et al. (2006). "Results of thyroidectomy in 101 cats with hyperthyroidism." Vet Surg 35(3): 287-93.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Harvey, A. M., A. Hibbert, et al. (2009). "Scintigraphic findings in 120 hyperthyroid cats." Journal of Feline Medicine & Surgery 11(2): 96-106.

The purpose of this study performed at the University of Bristol, United Kingdom, was to characterize the scintigraphic findings in a group of cats with hyperthyroidism to determine the location of the abnormal thyroid tissue. Thyroid scintigraphy relies on the selective uptake of a radionuclide by thyroid tissue. Hyperthyroidism is diagnosed by the increased level of uptake by the thyroid gland compared with salivary gland tissue. Thyroid scintigraphy also demonstrates the location of the abnormal thyroid tissue, which is useful when planning treatment options. The database of the Feline Centre at the University of Bristol was searched for cases of feline hyperthyroidism with good quality scintigraphic images between 1994 and 2007. Images from 120 cats were evaluated. Almost 1 in 5 hyperthyroid cats was found to have multiple areas of abnormal thyroid tissue and/or intrathoracic thyroid tissue where surgical thyroidectomy would not be curative. Another finding was that scintigraphy could not reliably differentiate between thyroid carcinoma and adenoma. The authors conclude that the possible presence of ectopic thyroid tissue should be discussed with all owners of hyperthyroid cats prior to performing surgical thyroidectomy. [SL]
>> PubMed Abstract

Related articles:
Henrikson, T. D., L. J. Armbrust, et al. (2005). "Thyroid to salivary ratios determined by technetium-99m pertechnetate imaging in thirty-two euthyroid cats." Vet Radiol Ultrasound 46(6): 521-3.
>> PubMed Abstract

Naan, E. C., J. Kirpensteijn, et al. (2006). "Results of thyroidectomy in 101 cats with hyperthyroidism." Vet Surg 35(3): 287-93.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Read More

Treatment of Ringworm in Cats

Mancianti, F., S. Dabizzi, et al. (2009). "A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis?" Journal of Feline Medicine & Surgery 11(2): 91-95.

In this study performed at the University of Pisa, Italy, the effect of pre-treatment with lufenuron on the effectiveness of enilconazole or griseofulvin for the treatment of feline ringworm was studied. Ringworm in cats is most commonly caused by the fungal agent, Microsoporum canis. A variety of treatment options have been recommended over the years, including both topical and systemic drugs. Lufenuron is a drug that interferes with chitin synthesis and is most commonly used to prevent flea infestations. It has also been proposed as an alternative treatment for ringworm, but with highly variable results when used as a sole agent. Lufenuron was given at 100 mg/kg biweekly for 8 weeks to 38 M. canis infected cats. Group A cats (13) were only treated with lufenuron. In Group B, 11 cats were pre-treated with lufenuron, and then treated with four weekly rinses of enilconazole (0.2% solution). In Group C, 14 cats were pre-treated with lufenuron, and then treated with oral griseofulvin at 50 mg/kg twice daily for 40 days. Twelve cats were used as controls in that they were given griseofulvin (7 cats) or enilconazole (5 cats), but not lufenuron. All cats except one given lufenuron alone were still infected at day 60. The authors conclude that lufenuron alone was found to be ineffective, but may have an immunomodulatory effect as a pre-treatment combined with other drugs. [SL]
>> PubMed Abstract

Related articles:
Nuttall, T. J., A. J. German, et al. (2008). "Successful resolution of dermatophyte mycetoma following terbinafine treatment in two cats." Veterinary Dermatology 19(6): 405-410.
>> PubMed Abstract

Sharma, R., S. de Hoog, et al. (2007). "A virulent genotype of Microsporum canis is responsible for the majority of human infections." J Med Microbiol 56(10): 1377-85.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Mancianti, F., S. Dabizzi, et al. (2009). "A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis?" Journal of Feline Medicine & Surgery 11(2): 91-95.

In this study performed at the University of Pisa, Italy, the effect of pre-treatment with lufenuron on the effectiveness of enilconazole or griseofulvin for the treatment of feline ringworm was studied. Ringworm in cats is most commonly caused by the fungal agent, Microsoporum canis. A variety of treatment options have been recommended over the years, including both topical and systemic drugs. Lufenuron is a drug that interferes with chitin synthesis and is most commonly used to prevent flea infestations. It has also been proposed as an alternative treatment for ringworm, but with highly variable results when used as a sole agent. Lufenuron was given at 100 mg/kg biweekly for 8 weeks to 38 M. canis infected cats. Group A cats (13) were only treated with lufenuron. In Group B, 11 cats were pre-treated with lufenuron, and then treated with four weekly rinses of enilconazole (0.2% solution). In Group C, 14 cats were pre-treated with lufenuron, and then treated with oral griseofulvin at 50 mg/kg twice daily for 40 days. Twelve cats were used as controls in that they were given griseofulvin (7 cats) or enilconazole (5 cats), but not lufenuron. All cats except one given lufenuron alone were still infected at day 60. The authors conclude that lufenuron alone was found to be ineffective, but may have an immunomodulatory effect as a pre-treatment combined with other drugs. [SL]
>> PubMed Abstract

Related articles:
Nuttall, T. J., A. J. German, et al. (2008). "Successful resolution of dermatophyte mycetoma following terbinafine treatment in two cats." Veterinary Dermatology 19(6): 405-410.
>> PubMed Abstract

Sharma, R., S. de Hoog, et al. (2007). "A virulent genotype of Microsporum canis is responsible for the majority of human infections." J Med Microbiol 56(10): 1377-85.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Read More

Feline Vaccine-Associated Sarcoma Treatment

Eckstein, C., F. Guscetti, et al. (2009). "A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcoma." Vet Comp Oncol 7(1): 54-68.

Feline vaccine-associated sarcomas occur in about 1 in 10,000 vaccinated cats, comprise about 40% of all skin tumors, and are the most frequent skin tumor in cats. These tumors are highly invasive and rapidly growing. This study, among other goals, examined the effect of curative radiation treatment on survival time after surgery. Curative treatment (higher dosages, more frequent administration) did improve outcome. Cats with a poorer prognosis and given reduced radiation therapy benefited from the addition of chemotherapy by increased survival time. Both protocols are legitimate options for vaccine-associated sarcomas. [MK]
>> PubMed Abstract

Related articles:
Kass, P. H., W. L. Spangler, et al. (2003). "Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats." J Am Vet Med Assoc 223(9): 1283-92.
>> PubMed Abstract

Romanelli, G., L. Marconato, et al. (2008). "Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007)." J Am Vet Med Assoc 232(8): 1193-9.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Eckstein, C., F. Guscetti, et al. (2009). "A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcoma." Vet Comp Oncol 7(1): 54-68.

Feline vaccine-associated sarcomas occur in about 1 in 10,000 vaccinated cats, comprise about 40% of all skin tumors, and are the most frequent skin tumor in cats. These tumors are highly invasive and rapidly growing. This study, among other goals, examined the effect of curative radiation treatment on survival time after surgery. Curative treatment (higher dosages, more frequent administration) did improve outcome. Cats with a poorer prognosis and given reduced radiation therapy benefited from the addition of chemotherapy by increased survival time. Both protocols are legitimate options for vaccine-associated sarcomas. [MK]
>> PubMed Abstract

Related articles:
Kass, P. H., W. L. Spangler, et al. (2003). "Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats." J Am Vet Med Assoc 223(9): 1283-92.
>> PubMed Abstract

Romanelli, G., L. Marconato, et al. (2008). "Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007)." J Am Vet Med Assoc 232(8): 1193-9.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Read More